Asia Pacific Prenatal & Newborn Genetic Testing Market: Size, Growth, Industry Share, Forecast And Analysis Report By 2027
The Asia Pacific prenatal and newborn
genetic testing market is expected to reach US$ 1,679.956 Mn in 2027 from US$
630.914 in 2018. The market is estimated to grow with a CAGR of 11.6% from
2019-2027.
The key factors responsible for the growth of the market in Asia
Pacific are rising burden of genetic diseases among infants, increasing
fertility rates and developing healthcare scenario with rising awareness among
populace regarding the benefits of prenatal testing. On the other hand, use of
digital microfluidics in newborn testing is likely to be a prevalent trend in
the future years. Soaring birth rates among developing economies are
responsible for fueling global baby boom. However, the rising birth rate also
contributes to rising birth defects and infants suffering from several genetic
diseases. According to a report published by Bill and Melinda Gates Foundation
in 2018, there are almost 250 babies born every minute around the globe.
Moreover, according to the Centers for Disease Control and Prevention, the
fertility rates for Hispanic women was highest in 2017 among Hispanic women
with 67.1 births per 1,000 women.
Get Sample PDF Of Asia
Pacific Prenatal & Newborn Genetic Testing Market @
Asian countries such as India and China also have high fertility rates due to factors such as effects of religion, inadequate supply of family welfare services, poverty, and others. According to the World Bank in 2016, the fertility rates in India were reported to be 2.23 births per women as compared to 1.80 in the United States and 1.62 in China. Moreover, neighboring countries, such as Pakistan also have alarming rates of fertility. In 2016, the birth rate in Pakistan was reported to be 3.48 births per woman as per the World Bank data. However, the birthrate in India has successfully reduced its high fertility rate, but still is high as compared to other developed nations. According to the United Nations (UN) report published on June 2019, the fertility rate has reduced to 2.1. Therefore, by 2050 additional 273 million people will be added to India’s population. The increasing number of parturient women across the world are thus likely to create increasing demand for prenatal and newborn genetic tests across the globe leading to the growth of the market.
Ask For Discount @
The Asia Pacific prenatal and newborn genetic testing market,
based on the disease indication was segmented into cystic fibrosis, sickle cell
anemia, downs syndrome, phenylketonuria, recurrent pregnancy loss, and
Antiphospholipid syndrome, and other diseases. In 2018, Down syndrome segment
held the largest share of the market, by disease indication. The highest share
of Down syndrome attributes to the high prevalence of this genetic abnormality
among fetuses and availability of multiple tests for its screening and
diagnostics. However, the sickle cell anemia segment is expected to grow at the
fastest rate during the coming year.
Some of the major primary and secondary sources for prenatal and newborn genetic testing included in the report are Food & Drug Administration (FDA), Indian Institutes of Technology (IITs), International Trade Administration (ITA), Japan Society of Obstetrics and Gynecology (JSOG), Council of Scientific and Industrial Research (cSIR), Pakistan Down Syndrome Association (PDSA) and others.
Reason to Buy
• Save and reduce time carrying out entry-level research by
identifying the growth, size, leading players and segments in the prenatal
& newborn genetic testing market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the regional prenatal & newborn genetic testing market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the regional prenatal & newborn genetic testing market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
About Us :
Intelligence
Market Research & Consulting, LLP (IMRC) is a global provider of research
reports, business intelligence & consulting services. We know and
understand the importance of market research data for your institution.
Therefore, we have teamed up with the leading research institutes and strategy
specialists to bring to you the latest, niche and most relevant statistical
research.
At IMRC,
we have one of the most exhaustive, highly reliable database of market research
reports sourced from publishers and authors after a thorough quality check and
screening of the market study and credentials. We have a team of key market
experts who evaluate the market size, growth prospects, end-use, applications,
value & supply chain and top vendors in the industry to help the clients to
take most accurate and logical business decisions without any vague
assumptions.
Contact Us:
699,
Butler St. Suite 1007
Saugatuck,
MI - 49453, United States.
Phone : +1 209 691 5657
Comments
Post a Comment